Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits.
Bhaskar V; Fox M; Breinberg D; Wong MH; Wales PE; Rhodes S; DuBridge RB; Ramakrishnan V; Investigational New Drugs, 2008, vol. 26, issue 1, p 7, ISSN 01676997. ISBN 01676997.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef